Citation Impact
Citing Papers
Sample processing obscures cancer-specific alterations in leukemic transcriptomes
2014
Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression
2009
Recurrent BRAF mutations in Langerhans cell histiocytosis
2010 Standout
Evolution of the Cancer Stem Cell Model
2014 Standout
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
2006
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases
2005 Standout
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
2005 Standout
A view on drug resistance in cancer
2019 StandoutNature
The FGF family: biology, pathophysiology and therapy
2009 Standout
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Genetics, epigenetics and pharmaco‐(epi)genomics in angiogenesis
2008
Wnt signaling in cancer
2016 Standout
Expression and functional role of negative signalling regulators in tumour development and progression
2010
Fundamental Cellular Processes Do Not Require Vertebrate-specific Sequences within the TATA-binding Protein
2003 StandoutNobel
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia
2013
Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
2012
Acute lymphoblastic leukaemia
2013
Oxidative stress and cancer: An overview
2012
Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins
2008
Cancer stem cells revisited
2017 Standout
Current insights into the regulation of programmed cell death by NF-κB
2006
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
RAS-targeted therapies: is the undruggable drugged?
2020
Relapsed childhood acute lymphoblastic leukaemia
2013
MAP kinase signalling pathways in cancer
2007 Standout
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
2003
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
2005 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Comparative Mechanisms of Branching Morphogenesis in Diverse Systems
2006
Intratumoral Heterogeneity of the Epigenome
2016
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
Sprouty1 Regulates Reversible Quiescence of a Self-Renewing Adult Muscle Stem Cell Pool during Regeneration
2010
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy
2011
Signaling to NF-κB
2004 Standout
Nephrin – a unique structural and signaling protein of the kidney filter
2007
Clonal evolution in cancer
2012 StandoutNature
Outdoor air pollution and asthma
2014 Standout
Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
2012
Modulation of signalling by Sprouty: a developing story
2004
Introduction to NF-κB: players, pathways, perspectives
2006 Standout
The Bcl-2 apoptotic switch in cancer development and therapy
2007 Standout
Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA
2010 Standout
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
The BCL-2 protein family: opposing activities that mediate cell death
2007 Standout
Sprouty proteins, masterminds of receptor tyrosine kinase signaling
2008
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Raf Kinase Inhibitory Protein Regulates Raf-1 but Not B-Raf Kinase Activation
2005
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
β-arrestin-mediated receptor trafficking and signal transduction
2011 StandoutNobel
The future of epigenetic therapy in solid tumours—lessons from the past
2013
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Darwin and evolutionary tales in leukemia
2009
Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF
2000
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
2011
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Role for the Amino-Terminal Region of Human TBP in U6 snRNA Transcription
1997 Science
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Impact of Environmental Chemicals on Lung Development
2010
Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?
2012
Reconstructing the DNA Methylation Maps of the Neandertal and the Denisovan
2014 StandoutScienceNobel
Cancer treatment and survivorship statistics, 2016
2016 Standout
Wound Healing: A Cellular Perspective
2018 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
2011
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Generation and Detection of Reactive Oxygen Species in Photocatalysis
2017 Standout
Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?
2012
Works of D. Morrison being referenced
FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein
1999
BRCA1 Augments Transcription by the NF-κB Transcription Factor by Binding to the Rel Domain of the p65/RelA Subunit
2003
Endogenous knockdown of survivin improves chemotherapeutic response in ALL models
2011
WT1 Activates a Glomerular-Specific Enhancer Identified from the Human Nephrin Gene
2004
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
2013
The Receptor Tyrosine Kinase Regulator Sprouty1 Is a Target of the Tumor Suppressor WT1 and Important for Kidney Development
2003
Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling
2005
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
2011
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia
2008
WT1 Induces Apoptosis through Transcriptional Regulation of the Proapoptotic Bcl-2 Family Member Bak
2005
Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly
1996
Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia
2012